High Growth Tech Stocks to Watch in the US May 2026
The United States market has shown a robust performance, climbing 3.2% in the last week and up 31% over the past year, with earnings forecasted to grow by 16% annually. In such a dynamic environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation potential and scalability to capitalize on these favorable market conditions.
Top 10 High Growth Tech Companies In The United States
|
Name |
Revenue Growth |
Earnings Growth |
Growth Rating |
|---|---|---|---|
|
|
21.86% |
24.70% |
★★★★★★ |
|
Fabrinet |
21.38% |
23.34% |
★★★★★★ |
|
Palantir Technologies |
29.10% |
29.45% |
★★★★★★ |
|
Marker Therapeutics |
61.33% |
65.71% |
★★★★★★ |
|
Tenaya Therapeutics |
58.52% |
60.10% |
★★★★★☆ |
|
Gorilla Technology Group |
54.35% |
96.69% |
★★★★★☆ |
|
Zscaler |
15.95% |
49.84% |
★★★★★☆ |
|
Circle Internet Group |
20.24% |
46.34% |
★★★★★☆ |
|
Duos Technologies Group |
36.60% |
141.19% |
★★★★★☆ |
|
KVH Industries |
25.44% |
135.75% |
★★★★★☆ |
Click here to see the full list of 60 stocks from our US High Growth Tech and AI Stocks screener.
We’re going to check out a few of the best picks from our screener tool.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Crexendo, Inc. offers cloud communication platform software and unified communications as a service both in the United States and internationally, with a market cap of $258.88 million.
Operations: Crexendo generates revenue primarily through its cloud communication platform software and unified communications services. The company operates in both domestic and international markets, focusing on providing comprehensive communication solutions.
Crexendo’s recent earnings report highlights a robust year-over-year revenue increase to $20.71 million, up from $16.06 million, despite a dip in net income to $0.578 million from $1.17 million previously. This performance underscores a significant 85.5% surge in earnings over the past year, outpacing the IT industry’s growth of 32.1%. Looking forward, Crexendo is not just resting on its laurels; it actively seeks acquisition opportunities to bolster its market position and drive future growth, supported by a new $5 million term debt arrangement aimed at strategic expansions rather than immediate necessity. This strategy reflects a proactive approach to scaling operations and enhancing profitability within the competitive tech landscape.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: ADMA Biologics, Inc. is a biopharmaceutical company that focuses on developing, manufacturing, and marketing specialty plasma-derived biologics for treating immune deficiencies and infectious diseases globally, with a market cap of approximately $2.38 billion.
Operations: ADMA Biologics generates revenue primarily through its ADMA Biomanufacturing segment, which accounts for $493 million, while its Plasma Collection Centers contribute $17.03 million.
ADMA Biologics showcased a robust financial performance in Q1 2026, with sales slightly dipping to $114.49 million from $114.8 million year-over-year, yet net income surged impressively to $45.33 million from $26.9 million, reflecting a strategic focus on operational efficiency and profitability. The FDA’s recent approval of ASCENIV for expanded use in pediatric patients underscores ADMA’s commitment to broadening its market reach and enhancing product offerings, which is crucial for sustaining growth in the competitive biotech landscape. This regulatory nod could potentially open new avenues for revenue generation and bolster the company’s position in immunodeficiency treatments, aligning with its innovative edge in plasma-derived therapies.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Arista Networks, Inc. develops, markets, and sells data-driven networking solutions for AI, data center, campus, and routing environments across various global regions with a market cap of $214.34 billion.
Operations: The company generates revenue primarily through the sale of networking solutions designed for diverse environments such as AI, data centers, campuses, and routing. Operating across the Americas, Europe, the Middle East, Africa, and the Asia-Pacific regions allows it to tap into a broad customer base.
Arista Networks has demonstrated a solid trajectory in its financial and operational performance, particularly evident in its Q1 2026 results where revenue soared to $2.71 billion from $2 billion the previous year, marking a significant annual growth rate. This surge is complemented by an increase in net income to $1.02 billion, up from $813.8 million, reflecting robust profitability alongside earnings per share growth from $0.65 to $0.81. The company’s commitment to innovation is underscored by its recent unveiling of the XPO optics module, which promises unprecedented throughput and rack density for AI networking applications—a move likely to keep Arista at the forefront of technological advancements in large-scale network infrastructures.
Taking Advantage
Ready To Venture Into Other Investment Styles?
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CXDO ADMA and ANET.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com